<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">The majority (~80%) of those infected by the severe acute respiratory syndrome (SARS) virus, the third member of the Coronavirus family, and second variant of SARS (SARS-CoV-2), will experience a mild to moderate flu-like respiratory tract illness, Coronavirus Disease 2019 (COVID-19), although it is conspicuously differentiated from just about every other pathogen targeting the human respiratory tree. Without equivocation, the SARS-CoV-2 virus is endowed with two fundamental characteristics, which when combined together, can foment incontrovertibly one of the most ominous semiologic courses of illness recognized in modern medicine.</p>
